Gene expression and TCR amino acid sequences selected by HLA‐A02 :01‐restricted CTLs specific to HTLV ‐1 in ATL patients
British Journal of Haematology · 2023
DOI: 10.1111/bjh.18918 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Machiko Kusuda und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Human T-lymphotropic virus 1, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Adult T‐cell leukaemia/lymphoma (ATL) is an aggressive malignancy of peripheral T cells caused by human T‐cell lymphotropic virus type‐1 (HTLV‐1). Tax is the most important regulatory protein for HTLV‐1. We aimed to reveal a unique amino acid sequence (AA) of complementarity‐determining region 3 (CDR3) of the T‐cell receptor (TCR)β and TCRα chains of HLA‐A*02:01‐restricted Tax 11–19 ‐specific cytotoxic T cells (Tax‐CTLs). The gene expression profiles (GEP) of Tax‐CTLs were assessed by the next‐generation sequence (NGS) method with SMARTer technology. Tax‐CTLs seemed to be oligoclonal, and their gene compositions were skewed. The unique motifs of ‘DSWGK’ in TCRα and ‘LAG’ in TCRβ at CDR3 were observed in almost all patients. Tax‐CTL clones harbouring the ‘LAG’ motif with BV28 had a higher binding score than those without either of them, besides a higher binding score associated with longer survival. Tax‐CTLs established from a single cell showed killing activities against Tax‐peptide‐pulsed HLA‐A2 + T2 cell lines. GEP of Tax‐CTLs revealed that genes associated with immune response activity were well preserved in long‐term survivors with stable status. These methods and results can help us better understand immunity against ATL, and should contribute to future studies on the clinical application of adoptive T‐cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan.
- Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medicial University, Shimotsuke, Japan.
ORCID-Profile: Machiko Kusuda, Hideki Nakasone, Yukiko Misaki, Shun-Ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Kusuda, M., Nakasone, H., Yoshimura, K., Okada, Y., Tamaki, M., Matsuoka, A., Ishikawa, T., Meno, T., Nakamura, Y., Kawamura, M., Takeshita, J., Kawamura, S., Yoshino, N., Misaki, Y., Gomyo, A., Tanihara, A., Kimura, S. I., Kako, S., & Kanda, Y. (2023). Gene expression and TCR amino acid sequences selected by HLA‐A02 :01‐restricted CTLs specific to HTLV ‐1 in ATL patients. British Journal of Haematology. https://doi.org/10.1111/bjh.18918
Vancouver
Kusuda M, Nakasone H, Yoshimura K, Okada Y, Tamaki M, Matsuoka A, et al. Gene expression and TCR amino acid sequences selected by HLA‐A02 :01‐restricted CTLs specific to HTLV ‐1 in ATL patients. British Journal of Haematology. 2023. doi:10.1111/bjh.18918
BibTeX
@article{Kusuda2023,
author = {Kusuda, Machiko and Nakasone, Hideki and Yoshimura, Kazuki and Okada, Yosuke and Tamaki, Masaharu and Matsuoka, Akari and Ishikawa, Takuto and Meno, Tomohiro and Nakamura, Yuhei and Kawamura, Masakatsu and Takeshita, Junko and Kawamura, Shunto and Yoshino, Nozomu and Misaki, Yukiko and Gomyo, Ayumi and Tanihara, Aki and Kimura, Shun-Ichi and Kako, Shinichi and Kanda, Yoshinobu},
title = {Gene expression and TCR amino acid sequences selected by HLA‐A02 :01‐restricted CTLs specific to HTLV ‐1 in ATL patients},
journal = {British Journal of Haematology},
year = {2023},
doi = {10.1111/bjh.18918}
}
EUVIMED